225 related articles for article (PubMed ID: 10546932)
1. Vitreous concentrations of TPA and plasminogen activator inhibitor are associated with VEGF in proliferative diabetic vitreoretinopathy.
Hattenbach LO; Allers A; Gümbel HO; Scharrer I; Koch FH
Retina; 1999; 19(5):383-9. PubMed ID: 10546932
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.
Baker EA; Bergin FG; Leaper DJ
Mol Pathol; 2000 Dec; 53(6):307-12. PubMed ID: 11193049
[TBL] [Abstract][Full Text] [Related]
3. Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
Am J Ophthalmol; 2002 Jun; 133(6):851-2. PubMed ID: 12036691
[TBL] [Abstract][Full Text] [Related]
4. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
[TBL] [Abstract][Full Text] [Related]
5. Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin.
Noma H; Funatsu H; Yamashita H; Kitano S; Mishima HK; Hori S
Arch Ophthalmol; 2002 Aug; 120(8):1075-80. PubMed ID: 12149062
[TBL] [Abstract][Full Text] [Related]
6. Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation.
Umeda N; Ozaki H; Hayashi H; Kondo H; Uchida H; Oshima K
Ophthalmic Res; 2002; 34(1):43-7. PubMed ID: 11834884
[TBL] [Abstract][Full Text] [Related]
7. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Ambati J; Chalam KV; Chawla DK; D'Angio CT; Guillet EG; Rose SJ; Vanderlinde RE; Ambati BK
Arch Ophthalmol; 1997 Sep; 115(9):1161-6. PubMed ID: 9298058
[TBL] [Abstract][Full Text] [Related]
8. [Enzymatically induced posterior vitreous detachment in proliferative diabetic vitreoretinopathy].
Hesse L; Kroll P
Klin Monbl Augenheilkd; 1999 Feb; 214(2):84-9. PubMed ID: 10218200
[TBL] [Abstract][Full Text] [Related]
9. Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin.
Funatsu H; Yamashita H; Noma H; Mochizuki H; Mimura T; Ikeda T; Hori S
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1042-7. PubMed ID: 12601027
[TBL] [Abstract][Full Text] [Related]
10. Relation of diabetic macular edema to cytokines and posterior vitreous detachment.
Funatsu H; Yamashita H; Ikeda T; Mimura T; Shimizu E; Hori S
Am J Ophthalmol; 2003 Mar; 135(3):321-7. PubMed ID: 12614749
[TBL] [Abstract][Full Text] [Related]
11. PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
Wakabayashi Y; Usui Y; Tsubota K; Ueda S; Umazume K; Muramatsu D; Goto H
Retina; 2017 Dec; 37(12):2317-2325. PubMed ID: 28098727
[TBL] [Abstract][Full Text] [Related]
12. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
[TBL] [Abstract][Full Text] [Related]
13. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.
Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
Am J Ophthalmol; 2002 Sep; 134(3):348-53. PubMed ID: 12208245
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
[TBL] [Abstract][Full Text] [Related]
15. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
Funatsu H; Yamashita H; Ikeda T; Mimura T; Eguchi S; Hori S
Ophthalmology; 2003 Sep; 110(9):1690-6. PubMed ID: 13129863
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Funatsu H; Yamashita H; Nakanishi Y; Hori S
Br J Ophthalmol; 2002 Mar; 86(3):311-5. PubMed ID: 11864890
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders.
Katsura Y; Okano T; Noritake M; Kosano H; Nishigori H; Kado S; Matsuoka T
Diabetes Care; 1998 Oct; 21(10):1759-63. PubMed ID: 9773744
[TBL] [Abstract][Full Text] [Related]
18. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
[TBL] [Abstract][Full Text] [Related]
19. Stimulation and inhibition of angiogenesis in diabetic retinopathy.
Funatsu H; Yamashita H; Noma H; Shimizu E; Yamashita T; Hori S
Jpn J Ophthalmol; 2001; 45(6):577-84. PubMed ID: 11754898
[TBL] [Abstract][Full Text] [Related]
20. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.
Adamis AP; Miller JW; Bernal MT; D'Amico DJ; Folkman J; Yeo TK; Yeo KT
Am J Ophthalmol; 1994 Oct; 118(4):445-50. PubMed ID: 7943121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
